Next Generation Sequencing (NGS) and patient pathways: What is the impact on clinical decision?

S. Coquerelle; M. Darlington; M. Michel; M. Durand; J. Gutton; I. Borget; S. Baffert; P. Marino; L. Perrier; I. Durand-Zaleski

doi:10.1093/annonc/mdy318.022

Journal Articles Annals of Oncology Year : 2018

Next Generation Sequencing (NGS) and patient pathways: What is the impact on clinical decision?

, , , , , , , (1) , ,

1

S. Coquerelle

Function : Author

M. Darlington

Function : Author

M. Michel

Function : Author

M. Durand

Function : Author

J. Gutton

Function : Author

I. Borget

Function : Author

S. Baffert

Function : Author

P. Marino

Function : Author

Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale

L. Perrier

Function : Author

I. Durand-Zaleski

Function : Author

Domains

Life Sciences [q-bio]

Jean-Charles DUFOUR : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-02146883

Submitted on : Tuesday, June 4, 2019-11:49:47 AM

Last modification on : Wednesday, November 3, 2021-9:44:43 AM

Dates and versions

hal-02146883 , version 1 (04-06-2019)

Identifiers

HAL Id : hal-02146883 , version 1
DOI : 10.1093/annonc/mdy318.022

Cite

S. Coquerelle, M. Darlington, M. Michel, M. Durand, J. Gutton, et al.. Next Generation Sequencing (NGS) and patient pathways: What is the impact on clinical decision?. Annals of Oncology, 2018, 29 (6), ⟨10.1093/annonc/mdy318.022⟩. ⟨hal-02146883⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

INSERM UNIV-AMU U1252

24 View

0 Download

Next Generation Sequencing (NGS) and patient pathways: What is the impact on clinical decision?

Domains

Dates and versions

Identifiers

Cite

Export

Collections

Altmetric

Share